glp-1 based therapeutics summit Meet with ICON experts at the GLP-1-Based to gain valuable insights on obesity clinical development and learn about our ready-to-deploy infrastructure designed to accelerate… GLP-1-Based Therapeutics Summit | Conference

However, many of these technologies remain preclinical or are early in development, and larger-scale, longer-term studies are required to more conclusively assess their long-term effectiveness, safety, and cost-efficiency before routine clinical use

Endocrinology 155 , 12801290, (2014)

63% of patients achieved more than 20% weight loss compared to 1% on lifestyle changes alone

Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans

Report chest pain, severe abdominal pain, or new psychiatric symptoms immediately

Drugmakers will get to extend the patent duration of a drug theyve already developed adding up to 20 years of patent coverage by combining it with a patch, creating a new type of combination product, according to DeAnn Smith of the law firm Foley Hoag